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There is little evidence from randomized trials showing that physical activity alone inﬂuences biomarker proﬁles in youths.
This study tested two hypotheses: (i) that elevated body fatness and poor ﬁtness would be associated with unfavorable levels
of cardiometabolic biomarkers in 8–12-y-old black girls (n = 242) and (ii) that a 10-mo PA intervention would have favorable
eﬀects on the fatness-related cardiometabolic biomarkers. At baseline, all fatness indices (i.e., percent body fat, visceral adipose
tissue, BMI, and waist circumference) were signiﬁcantly (P<0.05) associated with unfavorable levels of insulin, glucose, systolic
BP,diastolicBP,triglycerides, C-reactive protein (CRP),andﬁbrinogen.Aerobicﬁtnesswassigniﬁcantly(P<0.05)associatedwith
favorablelevelsof insulin,CRP, ﬁbrinogen, and HDL2.The PAintervention hadsigniﬁcantandfavorableeﬀects onﬁtness,fatness,
and two biomarkers—resting heart rate and LDL cholesterol. More research is needed to clarify what types of interventions can
enhance the cardiometabolic health of youths.
1.Introduction
The relatively high prevalence of obesity and overweight in
black females begins early in life [1]. Already in childhood,
higher levels of general and visceral adiposity are associated
with poorcardiometabolic biomarkerproﬁles[2].Moreover,
blackfemalesarealsoatgreaterriskofexhibitingunfavorable
levels of obesity-related cardiometabolic biomarkers that
lead to hypertension [3], type 2 diabetes [4], and coronary
heart disease [5]. Therefore, it is important to enhance our
understanding of these relations and to develop eﬀective
prevention strategies to reduce future risk of these diseases,
starting in childhood.
A recent review of the literature on the eﬀect of physical
activity (PA) on cardiometabolic biomarker proﬁles [6]
found evidence that PA, even without dietary intervention,
leads to favorable changes in biomarker proﬁle in obese
youths who exhibit unfavorable levels prior to the inter-
vention; however, there is little evidence from randomized
trials showing that PA alone inﬂuences biomarker proﬁles in
youths of all fatness levels, perhaps because the doses of PA
used in previous randomized trials of nonobese youths have
been rather modest.
This study tested two hypotheses: (i) that lower levels
of aerobic ﬁtness and higher levels of fatness would be as-
sociated with poorer cardiometabolic biomarker proﬁles in a
sample of young black girls who varied over the spectrum of
fatness and ﬁtness and (ii) that girls randomized to an after-
school PA program that utilized a relatively large PA dose
(i.e., 80min/day of moderate-vigorous PA, 5days/wk, 10mo
in duration) would exhibit beneﬁcial changes in biomarkers
compared to girls not randomized to the PA program. In2 International Journal of Pediatrics
addition, we explored two other questions dealing with indi-
vidual diﬀerences over the 10-mo period of the intervention:
(i) whether larger decreases in fatness and improvements in
ﬁtness would be associated with greater beneﬁcial changes in
biomarkers and (ii)whether, within the PA group, greater at-
tendance and higher PA intensity, as measured with heart
rate (HR) monitors during the PA sessions, would be asso-
ciated with larger beneﬁcial changes in the biomarkers.
2.Materialsand Methods
2.1.Subjects. 8–12-y-oldblackgirlswererecruitedfromlocal
elementary schools using ﬂyers. All black girls in third,
fourth,and ﬁfthgradeswereeligibleiftheymetthefollowing
criteria: (i) weighed less than 300lbs, the mechanical limit of
the dual-energy-X-ray (DXA) machine (ii) were not taking
any medications known to aﬀect metabolism, body com-
position or fat distribution and (iii) were able to participate
in regular PA. Subjects and their parents attended informa-
tion sessions and signed informed consent/assent forms in
accordance with the Human Assurance Committee of the
Georgia Health Sciences University (GHSU). We found in
previous studies that accepting only one sibling per family
resulted in eligible and interested potential subjects refusing
participation. Therefore, we decided to accept sisters to in-
crease study acceptability on the part of subjects and their
parents.
2.2. Testing. Subjects came to the Georgia Prevention Insti-
tute (GPI) for testing at the beginning of the study and after
10mo. Subjects presented early in the morning after a 10-h
fast. Pretesting started in late July and ended in mid-fall.
Subjects were tested and if randomized to the intervention
were integrated on a rolling basis. Subjects were paid $100
each for the baseline and posttest assessment.
2.3. Sexual Maturation. Pubertal stages were assessed by
pediatricians based on established criteria [7]. Examination
of the Tanner staging for breast and pubic hair development
was not refused by any of the subjects. None of the children
had hirsutism.
2.4.BodySizeandComposition. Height (cm) and weight (kg)
were measured by standard methods using a wall-mounted
stadiometer and a scale, respectively. Body mass index (BMI)
was calculated as weight (kg)/height (m2), and BMI percen-
tile was obtained from growth charts from the Centers for
Disease Control [8]. Waist circumference (cm) was meas-
ured using a measuring tape at the narrowest point of the
torso, below the rib cage and above the umbilicus. Total
body composition, including %BF, was obtained using DXA
(Hologic QDR-1000, Waltham, Mass, USA) as previously
described [9]. Visceral adipose tissue (VAT) was obtained
using magneticresonance imaging (MRI:1.5T General Elec-
tric Medical Systems, Milwaukee, Wis, USA), as previously
described [10]. The MRI equipment in the hospital was
not available at all times when subjects were being tested;
therefore, VAT was only available on a subset of subjects.
2.5. Hemodynamics. Resting hemodynamic measures were
made in the supine position after 10min of quiet rest with
arms at the side of the body and legs uncrossed. Systolic and
diastolic BP (SBP and DBP, resp.) and heart rate (HR) were
measured with a Dinamap monitor (Critikon, Inc., Tampa,
Fla, USA); ﬁve readings were made at 1-min intervals and
the last three were averaged.
2.6. Bioassays. Fasting blood samples were obtained from
participants. Serum was sent to the University of Alabama
(UAB) for the determination of fasting insulin and glucose
levels. Glucose was measured in 10uL sera using an Ekta-
chem DT II System (Johnson and Johnson Clinical Diagnos-
tics, Rochester, NY, USA). The intraassay coeﬃcient of vari-
ation was 0.61%;mean interassay coeﬃcient ofvariation was
1.45%. Insulin was assayed in duplicate 100uL aliquots of
sera by speciﬁc radioimmunoassay (Linco Research Inc., St.
Charles, MO); cross-reactivity with proinsulin is less than
0.2%. Assay sensitivity was 3.41uU/mL; intra-assay coeﬃ-
cient of variation was 3.7%.
Plasma concentrationsoftriglycerides(TG),totalcholes-
terol (TC), low-density lipoprotein cholesterol (LDLC), and
high-density lipoprotein cholesterol (HDLC) were measured
at the Emory Lipid Research Laboratory using homogeneous
enzymatic assays (Equal Diagnostics, Exton, Pa, USA).
Plasma concentrations of Apolipoprotein(Apo)A1, ApoB,
and lipoprotein(a) (Lp(a)) were determined using immuno-
turbidimetric methods (DiaSorin, Stillwater, Minn, USA).
ApoCIII was determined using an immunoturbidometric
assay kit (Wako Chemicals, Richmond, Va, USA). ApoE
was determined on the Beckman CX7 Chemistry analyzer
by immunoturbidometric method using the kit from Wako
Chemicals (Richmond, Va, USA). The segmental gradient
polyacrylamide gels (S-GGE 2.8/8.30) were prepared for the
determinations of LDL and HDL2 diameters [11]. Inﬂam-
matory and coagulation markers were assayed in the Inﬂam-
matory Core Lab of the GHSU. Serum C-reactive protein
(CRP)wasassayedinduplicateusingELISAs.Fibrinogenwas
measured using citrated plasma and was assayed in duplicate
using a BBL Fibrometer and reagents purchased from Biom-
erieux, (St. Louis, Mo, USA) as previously described [2].
2.7. Aerobic Fitness. Fitness was assessed using a multistage
treadmill test. Heart rate was monitored using a Polar Ac-
c u r e xP l u so rS 6 1 0H Rm o n i t o r( L a k eS u c c e s s ,L o n gI s l a n d ,
NY, USA). Oxygen consumption (VO2) was measured using
a Sensormedics Vmax 229 cardiopulmonary system (Yorba
Linda, Calif, USA). The treadmill protocol began with a 4-
min warm-up at 0% grade and 2.0mph. The speed was
then increased 0.5mph every 2min until reaching 3.0mph
at which time the grade increased to 2% for 2min, then in-
creased an additional 3% every 2min until reaching 20%
grade or exhaustion. Two indices of aerobic ﬁtness were
obtained: maximal oxygen consumption (VO2 max) and
oxygen consumption at a HR of 170bpm (VO2-170). Sub-
jects were considered to have attained VO2 max if they met
two of the following three criteria: (i) an increase in HR
<5bpm between the ﬁnal two workloads (ii) an increase
in VO2 <100mL between the ﬁnal two workloads andInternational Journal of Pediatrics 3
(iii) a respiratory exchange ratio >1.00. Although all subjects
were given verbal cues to give a maximal eﬀort, about half of
them stopped the test voluntarily before reaching VO2 max,
both at baseline and after the 10-mo intervention period.
In addition, only about half of the subjects who attained
VO2 max at baseline also did so at postintervention. Using
VO2 max as our index of ﬁtness would have resulted in a
50% decrease in sample size for the analyses, greatlyaﬀecting
power to detect signiﬁcant changes and diﬀerences between
groups. Therefore, a submaximal index of ﬁtness (VO2-170)
was used. Using all the treadmill workloads completed, we
computed individual regression equations of VO2 on HR for
each subject to obtain VO2-170.
2.8. After-School Intervention. The after-school intervention
isdescribed in detailelsewhere [12]. Brieﬂy,after pre-testing,
subjects within each school were randomized 3:2 to the in-
tervention or control groups, respectively. We randomized a
largernumbertotheinterventiongroup,becauseweplanned
to explore relations between biomarker changes and actual
doses of PA achieved by the girls (i.e., attendance and HR
during thePA sessions). The control groupreceived no inter-
vention. The intervention group stayed at their school at
the end of the day every day that school was in session. In
order to facilitate participation in the study, transportation
home was providedto the subjects. The intervention consist-
ed of 30min of homework time during which subjects were
provided with a healthy snack free of charge, and 80min
of PA. The PA component included 25min of skills devel-
opment, 35min of vigorous PA, and 20min of toning and
stretching. Subjects wore Polar Accurex Plus or S610 HR
monitors (Lake Success, Long Island, NY, USA) every day
during the PA portion of the program and were taught how
to maintain their HR above 150bpm during the 35-min
vigorous PA component of the intervention. Subjects re-
ceived small weekly prizes (e.g., bouncy balls, slinkies, pen-
cils, note pads, etc.) for maintaining good behavior, attitude,
and attendance.
2.9. Statistical Analysis. All variables were checked for nor-
mality ofdistributionusing normal probabilityplotspriorto
the analyses. The relationships of biomarkers with indices of
fatness and ﬁtness at baseline were analyzed using Spearman
rank correlationstoaccountforthenonnormal distributions
of some of the variables. No transformations were needed
for the changes from baseline. ANCOVA was performed to
identify signiﬁcant eﬀects of the intervention on changes
from baseline while adjusting for baseline values. Additional
covariates analyzed were age and sexual maturation. Inter-
actions between covariates and treatment group were
explored.Onlysigniﬁcant factors were retained inthemodel.
The diﬀerence between the adjusted change scores reﬂects
change in the intervention group relative to change in the
control group. A negative diﬀerence is a relative decrease in
comparison with controls even though both groups might
h a v es h o w na ni n c r e a s ef r o mb a s e l i n et o1 0 - m od u et o
growth. To investigate the eﬀects of changes in fatness and
ﬁtness on changes in biomarkers, we used Pearson corre-
lations. To investigate the eﬀectof attendanceto the program
or intensity of training on changes in biomarkers, we includ-
ed percent attendance or HR during the aerobic portion of
the intervention in an analysis that also included baseline
biomarker concentration, age, and sexual maturity. Statisti-
cal signiﬁcance was set at alpha = 0.05. SAS version 9.2 was
used for all analyses.
3.Results
The baseline characteristics for all the subjects are presented
in Table 1. Although the subjects were not selected based
on level of fatness, 21% were overweight and 31% were
obese [12]. Nonetheless, baseline values of biomarkers were
relatively normal. None of the subjects had fasting glucose
values that would have labeled them with a provisional diag-
n o s i so fd i a b e t e s( ≥7.0mmol/L [13]). Seven percent had
impaired fasting glucose (5.6–6.9mmol/L), and 93% had
normal values (<5.6mmol/L). Values for BP were also rel-
atively normal: 5% had SBP values above the 95th percentile
for age, sex, and height [14, 15], 1% had DBP values above
the 95th percentile for age, sex, and height, and <1% had
both SBP and DBP values above the 95th percentile.
Table 2 shows the baseline correlations of fatness indices
( % B F ,V A T ,B M I ,a n dw a i s tc i r c u m f e r e n c e )a n da e r o b i cﬁ t -
ness with each of the biomarkers. In the interests of par-
simony, and because of the intercorrelations among some of
thebiomarkers,weomittedseveralfromthecorrelationanal-
yses. Higher levels of the fatness indices were signiﬁcantly
associated with less favorable levels of all of the biomarkers
except diastolic BP; the correlations of BMI with LDLC and
apoB1 did not reach the 0.05 level of signiﬁcance (P<0.10).
Higherlevelsofaerobicﬁtness wereassociated with favorable
levelsofinsulin, systolicBP,TG,CRP,andﬁbrinogen.In gen-
eral, the fatness-biomarker correlations were substantially
higher than the ﬁtness-biomarker correlations.
Table 3 shows the baseline and postintervention bio-
marker values for the intervention and control groups, in
which all intervention subjects were included regardless of
their attendance at the after-school sessions. There were no
signiﬁcant diﬀerences between groups at baseline for any of
the biomarkers. Also shown are the adjusted change values
between the two groups. The baseline value of each depend-
ent variable was associated with its change value. For exam-
ple, those with a higher resting HR at baseline had a larger
decrease in HR over the 10-mo period. Signiﬁcant interven-
tion eﬀects were found only for resting HR and LDLC. There
was a slight trend for a favorable intervention eﬀect on TC
and CRP (P’s <0.10). Similar results were obtained when
eﬃcacy analyses were performed that included only subjects
who came at least 2 days/wk (data not shown).
Changes in body composition and ﬁtness of the girls
in this project were presented previously [12]. With respect
to the fatness and ﬁtness variables of particular interest to
the current paper, eﬀectiveness analyses showed that the
intervention group (n = 118), compared to the control
group (n = 83) had signiﬁcant (P<0.05) beneﬁcial chan-
ges in %BF (−2.01), VAT (−14.6cm3), BMI (−0.53), waist
circumference (−1.68cm), and aerobic ﬁtness (1.57mL/
kg/min).4 International Journal of Pediatrics
Table 1: Baseline subject characteristics.
Control Intervention
N Mean (SD) N Mean (SD) P value
Age (yrs) 102 9.6 (0.9) 140 9.5 (0.9) 0.31
Pubertal Status 97 2.3 (1.1) 134 2.1 (1.0) 0.11
Height (cm) 102 141.7 (9.4) 140 140.5 (9.4) 0.33
Weight (kg) 102 42.9 (15.1) 140 42.8 (13.8) 0.95
Waist (cm) 102 66.9 (11.7) 139 67.3 (11.6) 0.76
BMI (kg/m2) 102 21.0 (5.7) 140 21.3 (5.1) 0.64
Body Fat (%) 100 30.4 (12.6) 135 31.1 (11.7) 0.68
VO2-170 (mL/kg/min) 94 21.2 (4.9) 129 21.0 (5.2) 0.74
Means (±S D ) .S D :s t a n d a r dd e v i a t i o n ;B M I :b o d ym a s si n d e x ;V O 2-170: oxygen consumption at 170beats/min.
Table 2: Baseline Spearman correlations (P values) between aerobic ﬁtness and fatness indices with cardiometabolic biomarkers.
VO2-170 (mL/kg/min) %BF VAT (cm3) BMI (kg/m2)W a i s t ( c m )
Insulin, pmol/L −0.40 (<0.0001) 0.56 (<0.0001) 0.56 (<0.0001) 0.60 (<0.0001) 0.63 (<0.0001)
Glucose, mmol/L −0.10 (0.18) 0.32 (<0.0001) 0.30 (0.0002) 0.25 (0.0004) 0.33 (<0.0001)
SBP, mmHg −0.15 (0.03) 0.26 (<0.0001) 0.19 (0.01) 0.27 (<0.0001) 0.25 (<0.0001)
DBP, mmHg −0.06 (0.39) 0.12 (0.06) 0.12 (0.09) 0.08 (0.19) 0.09 (0.18)
TG, mmol/L −0.18 (0.02) 0.31 (<0.0001) 0.30 (0.0004) 0.33 (<0.0001) 0.39 (<0.0001)
LDLC, mmol/L −0.07 (0.35) 0.19 (0.01) 0.22 (0.01) 0.14 (0.054) 0.16 (0.03)
ApoB, mg/dL −0.13 (0.09) 0.19 (0.01) 0.21 (0.01) 0.12 (0.09) 0.15 (0.04)
ApoCIII, ng/mL −0.04 (0.64) 0.29 (<0.0001) 0.26 (0.002) 0.26 (0.0003) 0.35 (<0.0001)
HDLC, mmol/L 0.12 (0.14) −0.25 (0.0006) −0.29 (0.0004) −0.30 (<0.0001) −0.34 (<0.0001)
CRP, ng/mL −0.46 (<0.0001) 0.73 (<0.0001) 0.68 (<0.0001) 0.63 (<0.0001) 0.62 (<0.0001)
Fibrinogen, mg/dL −0.28 (0.0002) 0.37 (<0.0001) 0.37 (<0.0001) 0.35 (<0.0001) 0.32 (<0.0001)
SBP: systolic blood pressure; DBP: diastolic blood pressure; TG: triglycerides; LDLC: low-density lipoprotein cholesterol; Apo: apolipoprotein;H D L C :h i g h -
densitylipoprotein cholesterol; CRP: C-reactive protein.
The correlations between 10-mo changes in fatness and
ﬁtness, and changes in the biomarkers for all subjects from
both groups are presented in Table 4. Greater improvements
in ﬁtness were signiﬁcantly associated with greater increases
in HDLC and lesser changes in ﬁbrinogen. In addition,
greater increases in %BF were signiﬁcantly associated with
greater increases in insulin and LDLC. Further, greater in-
creases in BMI were signiﬁcantly associated with greater in-
creasesininsulin,andﬁbrinogen.Thehighestcorrelationco-
eﬃcients were shown for the relations between increases in
VAT and increases in CRP and ﬁbrinogen.
To obtain information about the dose-response relations
between the PA and the changes in biomarkers, we examined
therelations,withintheinterventiongroup,betweenchanges
in the biomarkers and two aspects of PA-dose-HR during
the aerobic portion of the session as an index of intensity,
and attendance at the PA sessions. Heart rate during the PA
sessions was not signiﬁcantly associated with changes in any
of the biomarkers. However, there was a signiﬁcant negative
relationship between PA-attendance and change in fasting
insulin (β =− 0.70, P<0.05). Subjects who attended the
program less than 60% of the time exhibited increases in
fasting insulin whereas those who attended at least 60% of
the time had no change or a slight decrease in fasting insulin.
4.Discussion
Children in Georgia have been shown to be heavier than
the national average [16]; therefore, it was not surprising to
ﬁnd that the sample in this study tended to be on the heav-
ier side despite not having been recruited on the basis of fat-
ness.Nonetheless,baselinevaluesofthecardiometabolicbio-
markers fell largely within normal ranges for girls in the 8–
12 y range of age. Speciﬁcally, this was the case for fasting
glucose [13]a n dB P[ 14, 15], as mentioned above, as well as
for the lipids (TG, TC, HDLC, and LDLC) [17], CRP [18],
and ﬁbrinogen [18]. Although there are no reference values
fortheapolipoproteinsorLDLsize forchildren, thevaluesin
this sample of black girls are similar to those found in other
studies of relatively healthy children [19, 20].
The descriptive baseline ﬁndings conﬁrmed our ﬁrst
hypothesis: the fatness indices were associated with unfavor-
ablevaluesofalmostallofthebiomarkersinvestigated.High-
er aerobic ﬁtness was associated with more favorable levels
of several of the biomarkers albeit with smaller correlations
than the fatness correlations. This is consistent with the
results of recent pediatric studies showing: (i) that fatness
and ﬁtness are correlated with unfavorable biomarker pro-
ﬁles in young children [21], and (ii) that cardiometabolic
biomarkers are more closely associated with fatness thanInternational Journal of Pediatrics 5
Table 3: Cardiometabolic biomarkers at baseline and at 10 months for the intervention and control groups with all intervention subjects
included regardless of attendance at the PA sessions (unadjusted mean [SD]).
Variable Baseline 10 Months Adjusted change (SE)∗ P value
Intervention Control Intervention Control
Insulin, pmol/L† 119.4 (84.8) 101.4 (59.9) 130.6 (79.7) 122.4 (57.1) −3.6 (8.9) 0.69
Glucose, mmol/L† 4.89 (0.39) 4.91 (0.43) 4.85 (0.37) 4.89 (0.38) −0.03 (0.06) 0.63
SBP, mmHg‡ 104.1 (7.5) 102.4 (9.1) 105.1 (8.3) 103.8 (7.6) 0.5 (1.0) 0.64
DBP, mmHg‡ 59.0 (5.6) 59.5 (5.7) 58.3 (6.5) 58.8 (5.4) −0.3 (0.8) 0.72
HR, bpm‡ 79.6 (9.2) 79.8 (8.9) 74.1 (8.9) 76.9 (8.3) −2.7 (1.1) 0.01
TC, mmol/L† 4.18 (0.83) 4.15 (0.70) 4.01 (0.74) 4.15 (0.67) −0.15 (0.09) 0.08
TG, mmol/L† 0.66 (0.30) 0.63 (0.30) 0.77 (0.37) 0.71 (0.32) 0.04 (0.05) 0.46
HDLC, mmol/L† 1.34 (0.32) 1.29 (0.28) 1.36 (0.31) 1.34 (0.31) −0.01 (0.04) 0.73
LDLC, mmol/L† 2.67 (0.85) 2.67 (0.69) 2.47 (0.70) 2.67 (0.75) −0.20 (0.10) 0.04
LP(a), mg/dL† 45.5 (30.1) 50.6 (42.8) 47.8 (31.1) 57.3 (48.1) −4.48 (3.59) 0.21
LDL size, nm† 26.1 (0.69) 26.2 (0.69) 25.7 (0.82) 25.8 (0.72) −0.09 (0.14) 0.50
%HDL
†
2 36.9 (20.3) 36.7 (20.2) 36.1 (20.3) 35.8 (17.6) 0.17 (3.30) 0.96
ApoA1, mg/dL† 132.8 (32.3) 124.3 (22.7) 126.2 (22.1) 125.3 (20.7) −1.31 (3.68) 0.72
ApoB, mg/dL† 77.6 (29.9) 77.3 (26.1) 71.9 (26.6) 74.1 (21.9) −2.3 (4.3) 0.60
ApoCIII, ng/mL† 12.0 (3.8) 11.4 (3.9) 11.1 (4.2) 11.5 (4.3) −0.62 (0.69) 0.37
ApoE, ng/mL† 5.26 (1.49) 5.03 (1.75) 5.04 (1.56) 4.78 (1.56) 0.09 (0.20) 0.66
CRP, ng/mL† 757.3 (1571.0) 694.2 (883.6) 597.9 (1333.7) 795.8 (1120.5) −245.8 (145.2) 0.09
Fibrinogen, mg/dL† 2.72 (0.51) 2.77 (0.55) 2.89 (0.50) 2.91 (0.60) 0.02 (0.08) 0.83
SD: standard deviation; SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rate; TC: total cholesterol; TG: triglycerides; HDLC: high-
density lipoprotein cholesterol; LDLC: low-density lipoprotein cholesterol; Lp(a): lipoprotein(a); VLDL: very low-density lipoprotein; Apo: apolipoprotein;
CRP: C-reactive protein.
∗Change estimates and standard errors (SE) are the diﬀerences between intervention and control groups adjusted for age and baseline value.
†Intervention N = 74, Control N = 60.
‡Intervention N = 118, Control N = 82.
Table 4: Pearson correlations (P values) between changes in fatness and ﬁtness indices and changes in cardiometabolic biomarkers.
VO2-170 (mL/kg/min) %BF VAT (cm3)B M I ( k g / m 2)W a i s t ( c m )
Insulin, pmol/L −0.16 (0.1) 0.23 (0.01) 0.01 (0.92) 0.32 (0.0002) 0.19 (0.03)
Glucose, mmol/L 0.09 (0.35) 0.03 (0.72) 0.05 (0.66) 0.10 (0.24) 0.06 (0.48)
SBP, mmHg 0.04 (0.60) −0.02 (0.74) −0.01 (0.95) −0.017 (0.81) 0.05 (0.50)
DBP, mmHg −0.01 (0.89) −0.07 (0.35) −0.04 (0.67) −0.11 (0.11) −0.05 (0.52)
TG, mmol/L −0.03 (0.79) 0.06 (0.48) −0.17 (0.19) −0.001 (0.99) −0.06 (0.50)
LDLC, mmol/L −0.18 (0.07) 0.22 (0.01) 0.20 (0.11) 0.14 (0.13) 0.08 (0.35)
ApoB, mg/dL −0.12 (0.22) 0.07 (0.45) −0.005 (0.97) 0.09 (0.33) −0.01 (0.93)
ApoCIII, ng/mL 0.04 (0.66) −0.01 (0.88) 0.10 (0.45) −0.03 (0.73) 0.10 (0.27)
HDLC, mmol/L 0.21 (0.03) −0.07 (0.46) −0.09 (0.47) −0.08 (0.35) −0.05 (0.54)
CRP, ng/mL −0.16 (0.13) 0.08 (0.43) 0.46 (0.0004) 0.04 (0.69) 0.12 (0.20)
Fibrinogen, mg/dL −0.22 (0.02) 0.14 (0.12) 0.39 (0.001) 0.17 (0.05) 0.23 (0.008)
SBP: systolic blood pressure; DBP: diastolic blood pressure; TG: triglycerides; LDLC: low-density lipoprotein cholesterol; Apo: apolipoprotein;H D L C :h i g h -
densitylipoprotein cholesterol; CRP: C-reactive protein.
with ﬁtness [6]. It is noteworthy that for both fatness and
ﬁtness the correlations were especially high for insulin and
CRP, suggesting that insulin metabolism and inﬂammatory
processes are especially sensitive to variations in lifestyle.
Althoughthe intervention imparted a substantial dose of
PA on the girls and had a signiﬁcant impact on their fatness
and ﬁtness, our second hypothesis was not fully supported:
we found few signiﬁcant eﬀects of the PA intervention on
biomarker values. This result raises questions about the
value of PA alone to improve the cardiometabolic biomarker
proﬁles of black girls in the general population who are not
preselected to have unfavorable baseline proﬁles. These ﬁnd-
ings also demonstrate the important distinction between ob-
servational studies and randomized trials. If, in fact, there
is a cause-eﬀect relationship between fatness and biomarker
proﬁles, it may take longer than 10mo for the PA-induced
changes in fatness to be translated into biomarker changes.
It was noteworthy that favorable decreases in resting HR
and LDLC were seen in the intervention group, especially
given that the levels of both of these variables were within6 International Journal of Pediatrics
normal ranges for the majority of children at baseline. These
results are consistent with the results of previous PA trials
involving the general population of youths [6]. Addition-
ally, changes in total cholesterol and CRP following the
intervention were marginally signiﬁcant (P<0.10). Other
studies of PA in children and adolescents, including over-
weight adolescents who had signiﬁcant decreases in fatness,
failed to show beneﬁcial changes in CRP [22–24]; however,
these interventions may have been too short—eight and
twelve weeks—to show beneﬁcial eﬀects. Taken together,
these results suggest that beneﬁcial changes in some cardi-
ometabolic biomarkers may occur with PA even within
children whose levels are relatively normal for their age,
provided that the PA is of suﬃcient intensity and duration.
We failed to show that PA intensity was associated with
change in biomarker levels within the intervention group.
This maybebecause wetried tokeepall thechildrenworking
at a relatively high intensity, rather than allowing intensity
to vary. Hence, there may not have been enough variability
in intensity to reveal relationships. In a meta-analysis study
of adults, LDLC was the only lipid or lipoprotein associated
with training intensity [25, 26]. Furthermore, the only
biomarker that we found to be associated with frequency of
attendance was fasting insulin.
Onewaytoexplainthediscrepancybetweentheresultsof
observational and intervention studies is to consider that the
observational studies provide information about a relation-
ship that has evolved over a long period of time; for exam-
ple,youthswho havebeensedentary overseveralyearsbefore
the measurements have gradually worsened their body com-
position and biomarker proﬁle, with the result that a rela-
tionship between high levels of fatness and poor biomarker
proﬁle is clearly observed. Similarly, prospective observa-
tional studies that are carried out over several years time into
theadultyearsmayshowthatchangesinPAareaccompanied
byworseningbiomarkerproﬁle[15].Becauseofthediﬃculty
of conducting randomized controlled trials over such long
periods of time, conclusive evidence from intervention trials
is quite diﬃcult to obtain.
Our ﬁndings concerning the relations of changes in fat-
ness to changes in biomarkers over the 10-mo duration of
the trial are provocative and may suggest hypotheses to be
further tested in future studies. Lesser increases in VAT were
most highly correlated with favorable changes in CRP and
ﬁbrinogen. These results are consistent with the suggestion
thatvisceral adiposity is an especially important inﬂuenceon
some aspects of cardiometabolic health [2, 27].
This study had several notable strengths. First, it focused
on a speciﬁc demographic group—black females—who are
at elevated risk of obesity and obesity-associated diseases;
this focus enabled us to use physical activities in the PA ses-
sions that we had previously found to be especially enjoyable
to black girls. Second, the subjects were relatively young,
enabling us to show substantial relations of fatness and ﬁt-
ness to biomarker proﬁle early in life. Third, we measured
general and visceral adiposity with high-technology imaging
techniques, and aerobic ﬁtness with a multistage treadmill
test. Fourth, we investigated a wide variety of biomarkers,
enabling us to explore which ones were more or less sensitive
to variations in fatness and ﬁtness, and sensitive to the in-
ﬂuence of a PA intervention. Perhaps most important, we
determined the results of a randomized trial that involved
a relatively large dose of PA over a relatively long period of
time.
One limitation of the study concerns the selection of the
biomarkers. Recent research has identiﬁed other inﬂamma-
tory biomarkers that may be responsive to PA interventions,
such as IL-6, TNFα as well as anti-inﬂammatory markers
(i.e., IL-4 and IL-10) [28, 29]; these should be investigated
in future PA studies of youths.
5.Conclusion
This study showed that lifestyle factors such as high body
fatness and low aerobic ﬁtness were associated with unfa-
vorable levels of many cardiometabolic biomarkers in young
black girls. However, a 10-mo intervention, that had favor-
able eﬀects on body composition and ﬁtness, had signiﬁcant
eﬀects on only a small number of the biomarkers. These re-
sults highlight the important diﬀerences between observa-
tional designs and randomized controlled trials. More re-
search isneededinwhich variousdosesofPAare imparted to
youthsoverperiods ofseveralyears to uncoverthe long-term
relations of fatness and ﬁtness to cardiometabolic health in
youths.
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